School of Psychology, University of New South Wales.
Clinical Research Unit for Anxiety and Depression, School of Psychiatry, University of New South Wales at St. Vincent's Hospital.
J Consult Clin Psychol. 2018 Jan;86(1):89-98. doi: 10.1037/ccp0000248. Epub 2017 Nov 27.
To examine the efficacy of an Internet-delivered cognitive-behavioral therapy (iCBT) program for health anxiety compared to an active psychoeducation control group.
Individuals (N = 86, mean age: 30 years, 87% female) with a Diagnostic and Statistical Manual of Mental Disorders (5th ed.) diagnosis of illness anxiety disorder or somatic symptom disorder with health anxiety were randomized to either a 6-lesson clinician-guided iCBT program for health anxiety (n = 45) or an active control group who received anxiety psychoeducation, clinical support, and monitoring (control, n = 41) over a 12-week period.
Both groups experienced significant improvements between baseline and posttreatment on self-report measures of health anxiety, depression, general anxiety, and functional impairment. Intention-to-treat analyses indicated that the iCBT group experienced greater improvements in health anxiety on the Short Health Anxiety Inventory (SHAI) compared to controls (between-groups effect size = 1.39, 95% confidence interval [0.87, 1.93]), and a greater proportion of the iCBT group showed clinically reliable change on the SHAI (84% vs. 34% in the control group). Similarly, the iCBT group outperformed the control group on secondary measures of depression, generalized anxiety, functional impairment, maladaptive cognitions, body hypervigilance, safety behaviors and avoidance, and intolerance of uncertainty. Gains were maintained at 3-month follow-up in the iCBT group.
iCBT for health anxiety is more effective than psychoeducation, clinical support, and monitoring, and presents an efficacious and accessible treatment option for people with health anxiety. (PsycINFO Database Record
研究与积极的心理教育对照相比,互联网提供的认知行为疗法(iCBT)对健康焦虑的疗效。
将符合《精神障碍诊断与统计手册》(第五版)疾病焦虑障碍或躯体症状障碍伴健康焦虑诊断的个体(N=86,平均年龄:30 岁,87%为女性)随机分为 6 节临床指导的 iCBT 健康焦虑程序组(n=45)或接受焦虑心理教育、临床支持和监测的积极对照组(n=41),为期 12 周。
两组在基线和治疗后均在健康焦虑、抑郁、一般焦虑和功能障碍的自我报告测量上有显著改善。意向性治疗分析表明,与对照组相比,iCBT 组在短期健康焦虑量表(SHAI)上的健康焦虑改善更大(组间效应大小=1.39,95%置信区间[0.87,1.93]),且 iCBT 组中更多的患者在 SHAI 上显示出临床可靠的变化(84%比对照组的 34%)。同样,iCBT 组在次要的抑郁、一般焦虑、功能障碍、适应不良认知、身体过度警觉、安全行为和回避以及不确定性不耐受方面的表现优于对照组。在 iCBT 组中,收益在 3 个月的随访中得到维持。
iCBT 治疗健康焦虑比心理教育、临床支持和监测更有效,为健康焦虑患者提供了一种有效且易于获得的治疗选择。